1 / 32

DIABETES MELLITUS IN CHILDREN: CLINICAL FEATURES , DIAGNOSTICS AND TREATMENT

DIABETES MELLITUS IN CHILDREN: CLINICAL FEATURES , DIAGNOSTICS AND TREATMENT. Prof. H.A. Pavlyshyn. Risk factors. Risk factors. Risk factors. Clinical classification of DM type 1. DM severity criteria. Mild form Absence of ketoacidosis in anamnesis

barajas
Télécharger la présentation

DIABETES MELLITUS IN CHILDREN: CLINICAL FEATURES , DIAGNOSTICS AND TREATMENT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DIABETES MELLITUS IN CHILDREN: CLINICAL FEATURES, DIAGNOSTICS AND TREATMENT Prof. H.A. Pavlyshyn

  2. Risk factors

  3. Risk factors

  4. Risk factors

  5. Clinical classification of DM type1.

  6. DM severity criteria • Mild form • Absence of ketoacidosis in anamnesis • Absence of micro- and macroangiopathies • Treatment consists of diet, physical exercises, phytotherapy (it’s enough for ideal glycemic control maintaining)

  7. DM severity criteria • Moderate form • In anamnesis – ketoacidosis (I-II stages) • Presence of diabetic retinopathy I st., diabetic nephropathy I-III st. or diabetic arthropathy I st. • For achievement of ideal glycemic control is necessary to use insulin, or oral drug therapy or combination of both

  8. DM severity criteria • Severe form • Non stable course of the disease (frequent ketoacidosis cases or coma in anamnesis) • Presence of different chronic complications • Patients need permanent insulin injections

  9. Laboratory criteria of glycemic control

  10. The main evident signs of the DM type 1: • hyperglycemia - glucose uptake by cells decreased - glucose utilisation by cells decreased • glycosuria • polyuria - excessive urine production - blood glucose levels exceed the rate of glomerular filtration by the kidneys • glucose appears in the urine and acts as an osmotic diuretic • polydipsia - due to dehydration • polyphagia - excessive eating - hypothalamic control of appetite has insulin sensitive transport systems • weight loss • fatigue and weakness

  11. Diagnostic criteria: • A random blood glucose level greater than 11,1 mmol/l (i.e.>200 mg/dl), which is verified on a repeat test, is sufficient to make the diagnosis of DM or • Fasting blood glucose > 6,1 mmol/l (>110 mg/ dl) (fasting is no food for > 8 hours), which is verified on a repeat test, is sufficient to make the diagnosis of DM

  12. ComplicationsTrophic changes in the skin

  13. Complications Trophic changes in the skin

  14. Complicationsdiabetic nephropathy

  15. Complicationsdiabetic retinopathy

  16. Oral glucose tolerance test (OGTT) Obtain a fasting blood sugar level, then administer per os glucose load (1.75 g/kg for children [max 75 g]). Check blood glucose concentration again after 2 hours.

  17. Optimal therapy for diabetes mellitus must include • Insulin • A regimen for physical fitness • Psychological support • Nutritional management

  18. Daily insulin doses for children:

  19. Insulin has 3 basic formulations: • short-acting, regular insulin (aktrapid) • medium- or intermediate-acting (protaphan, isophane, lente) • and long-acting (ultralente)

  20. The main rules of insulinotherapy im children: • In ketoacidosis should be used only regular insulin • Optimal frequency of injections is 4-5 times per day (if 4 times – 9 a.m.(regular), 13 p.m.(regular), 18 p.m. (regular), 22 p.m (medium-acting); if 5 times – 6 a.m.(regular), 9 a.m.(regular), 14 p.m. (regular), 19 p.m. (regular), 23 p.m (regular); • Can be used insulin pompes

  21. The catheter at the end of the insulin pump is inserted through a needle into the abdominal fat of a person with diabetes.

  22. Designer Ellaluna Taylor has come up with her Flex insulin pump system that targets active diabetes sufferers, as this system functions as a “unique prosthetic skin” that can be worn under clothing, functioning as a discreet glucose management solution. It comes with a PDA-like glucose eReader that will talk to the device, where the latter runs on soft battery technology while its MEMS Nano Pump is used for increased dosage accuracy and reliability.

  23. Thanks for attention

More Related